Hypertension and current issues in compliance and patient outcomes.
Economic and human costs associated with untreated or inadequately controlled hypertension and its complications continue to be an issue in the United States despite the availability of numerous antihypertensive agents. Knowledge of hypertension, product profiles, tolerability concerns, convenience of dosing, health-related quality of life effects, and cost of therapy are some of the factors that may influence the compliance of patients to their medication regimens. Recent reports on patient noncompliance have focused on patient-provider relationships, psychosocial barriers, home blood pressure monitoring, and electronic monitoring systems to improve blood pressure control. The use of health-related quality of life assessment in antihypertensive studies and in routine clinical practice provides another opportunity to optimize a patient's regimen for short- and long-term hypertension control in a cost-effective manner.
Zyczynski
T M
TM
AstraZeneca, LP, Health Economics and Outcomes Research, 725 Chesterbrook Boulevard, Wayne, PA 19087-5677, USA.
Coyne
K S
KS
D000959:Antihypertensive Agents / Q000191:economics / Q000627:therapeutic use; D018660:Blood Pressure Monitoring, Ambulatory / Q000191:economics; D003362:Cost-Benefit Analysis; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000191:economics / Q000523:psychology; D017063:Outcome Assessment, Health Care; D010349:Patient Compliance; D010817:Physician-Patient Relations; D011788:Quality of Life / Q000523:psychology
D000959:Antihypertensive Agents